Abstract
A SUMMARY One-Year Follow-Up of ZUMA- 2, the Multicenter, Registrational Study of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma KT......
小提示:本篇文献需要登录阅读全文,点击跳转登录